Journal
CANCER RESEARCH
Volume 81, Issue 10, Pages 2651-2665Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-20-0066
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81530007, 81970103, 31725013]
- CAMS Innovation Fund for Medical Sciences [2017-I2M-3-009, 2017-I2M-1-015, 2019-I2M-2-001]
- CAMS Young Talents Award Program [2018RC310013]
- National Key Research and Development Program of China [2016YFA0100601]
- National Key Basic Research Program of China [2015CB943001]
- Medical Epigenetics Research Center, CAMS [2017PT31035]
- CAMS [2017-I2M-BR-04]
Ask authors/readers for more resources
This study reveals the oncogenic role of YTHDF1 in gastric cancer, showing its regulation of the Wnt/β-catenin signaling pathway through m(6)A modification. Inhibition of YTHDF1 can reduce gastric cancer cell proliferation and tumorigenesis, suggesting a new approach for targeting epigenetic regulators in cancer treatment.
N-6-methyladenosine (m(6)A) is the most prevalent internal RNA modification in mammals that regulates homeostasis and function of modified RNA transcripts. Here, we aimed to investigate the role of YTH m(6)A RNA-binding protein 1 (YTHDF1), a key regulator of m(6)A methylation in gastric cancer tumorigenesis. Multiple bioinformatic analyses of different human cancer databases identified key m(6)A-associated genetic mutations that regulated gastric tumorigenesis. YTHDF1 was mutated in about 7% of patients with gastric cancer, and high expression of YTHDF1 was associated with more aggressive tumor progression and poor overall survival. Inhibition of YTHDF1 attenuated gastric cancer cell proliferation and tumorigenesis in vitro and in vivo. Mechanistically, YTHDF1 promoted the translation of a key Wnt receptor frizzled7 (FZD7) in an m(6)A-dependent manner, and mutated YTHDF1 enhanced expression of FZD7, leading to hyperactivation of the Wnt/beta-catenin pathway and promotion of gastric carcinogenesis. Our results demonstrate the oncogenic role of YTHDF1 and its m(6)A-mediated regulation of Wnt/beta-catenin signaling in gastric cancer, providing a novel approach of targeting such epigenetic regulators in this disease. Significance: This study provides a rationale for controlling translation of key oncogenic drivers in cancer by manipulating epigenetic regulators, representing a novel and efficient strategy for anticancer treatment. [GRAPHICS] .
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available